Article citationsMore>>

Russell, S., Bennett, J., Wellman, J.A., et al. (2017) Efficacy and Safety of Voretigene Neparvovec (AAV2-hRPE65v2) in Patients with RPE65-Mediated Inherited Retinal Dystrophy: A Randomised, Controlled, Open-Label, Phase 3 Trial. The Lancet, 390, 849-860. https://doi.org/10.1016/S0140-6736(17)31868-8

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top